Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity

被引:0
|
作者
P-J Yu
G Ferrari
L Pirelli
A C Galloway
P Mignatti
G Pintucci
机构
[1] The Seymour Cohn Cardiovascular Research Laboratory,Department of Cardiothoracic Surgery
[2] New York University School of Medicine,Department of Cell Biology
[3] New York University School of Medicine,undefined
来源
Oncogene | 2008年 / 27卷
关键词
endothelial cells; inflammation; migration; proliferation; proteolysis; serine proteinases;
D O I
暂无
中图分类号
学科分类号
摘要
The fgf-2 gene encodes low molecular weight (LMW, 18 kDa) and high molecular weight (HMW, 22–24 kDa) forms that originate from alternative translation of a single mRNA and exhibit diverse biological functions. HMW fibroblast growth factor-2 (FGF-2) inhibits cell migration and induces cell transformation or growth arrest in a cell type- and dose-dependent fashion. Conversely, LMW FGF-2 upregulates both cell proliferation and migration in most cell types. Although transcriptional and translational regulation of HMW and LMW FGF-2 has been extensively investigated, little is known about post-translational control of their relative expression. Here we report that thrombin, a key coagulation factor and inflammatory mediator, cleaves HMW FGF-2 into an LMW FGF-2-like form that stimulates endothelial cell migration and proliferation. The effect of thrombin on these cell functions requires HMW FGF-2 cleavage. This post-translational control mechanism adds a novel level of complexity to the regulation of FGF-2, and links the activities of thrombin and FGF-2 in patho-physiological processes in which both molecules are expressed.
引用
收藏
页码:2594 / 2601
页数:7
相关论文
共 50 条
  • [1] Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity
    Yu, P-J
    Ferrari, G.
    Pirelli, L.
    Galloway, A. C.
    Mignatti, P.
    Pintucci, G.
    ONCOGENE, 2008, 27 (18) : 2594 - 2601
  • [2] Basic fibroblast growth factor (FGF-2): The high molecular weight forms come of age
    Yu, Pey-Jen
    Ferrari, Giovanni
    Galloway, Aubrey C.
    Mignatti, Paolo
    Pintucci, Giuseppe
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (05) : 1100 - 1108
  • [3] The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism
    Delrieu, I
    FEBS LETTERS, 2000, 468 (01) : 6 - 10
  • [4] Thrombin cleaves in vitro FGF-2 and modulates its biological activity
    Totta, P.
    De Cristofaro, R.
    Capogrossi, M. C.
    Facchiano, A.
    THROMBOSIS RESEARCH, 2007, 120 : S155 - S155
  • [5] Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization
    Perollet, C
    Han, ZC
    Savona, C
    Caen, JP
    Bikfalvi, A
    BLOOD, 1998, 91 (09) : 3289 - 3299
  • [6] Basic fibroblast growth factor(FGF-2) in mouse tooth morphogenesis
    Russo, LG
    Maharajan, P
    Maharajan, V
    GROWTH FACTORS, 1998, 15 (02) : 125 - +
  • [7] Basic fibroblast growth factor (FGF-2) signal interruption in arterial injury
    Golden, MA
    JOURNAL OF VASCULAR SURGERY, 2001, 33 (06) : 1308 - 1309
  • [8] The regulation of basic fibroblast growth factor (FGF-2) through limited bioavailability
    Baird, A
    GROWTH FACTORS AND WOUND HEALING: BASIC SCIENCE AND POTENTIAL CLINICAL APPLICATIONS, 1997, : 27 - 36
  • [9] Ischemia increases the angiogenic potency of basic fibroblast growth factor (FGF-2)
    Angel, MF
    MICROSURGERY, 1996, 17 (08) : 457 - 458
  • [10] Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2
    Maher, PA
    JOURNAL OF CELL BIOLOGY, 1996, 134 (02): : 529 - 536